总25-羟基维生素D水平预测骨折风险:日本人群骨质疏松(JPOS)队列研究15年随访结果
该研究基于日本女性队列,基线共1437名≥50岁社区居住女性,最终分析1211名无早期绝经或影响骨代谢疾病的女性,随访15年。结果显示25(OH)D<20 ng/mL者5年内临床骨折、非椎体骨折和脆性骨折风险显著升高,非椎体骨折风险在15年随访中仍显著。
要点
- 25(OH)D<20 ng/mL与≥20 ng/mL相比,5年内临床、非椎体和脆性骨折风险显著增加。
- 5年内非椎体骨折风险在<10和10–20 ng/mL组均显著高于≥30 ng/mL组,HR分别为6.55和3.49。
- 调整年龄和股骨颈骨密度后,<20 ng/mL组非椎体骨折风险在15年随访中仍显著(HR 1.42)。
核心结论
- 低25(OH)D水平,尤其是<20 ng/mL,与日本女性骨折风险升高相关。
研究设计与样本
- 日本女性队列研究,基线调查1437名≥50岁社区居住女性,1236名提供15年随访期间骨折信息,最终分析1211名无早期绝经或影响骨代谢疾病的女性。
主要发现
- 15年随访期间共确认269例临床骨折事件,其中224例非椎体骨折、149例脆性骨折。
- 5年内临床骨折发生率按25(OH)D水平(<10、10–20、20–30、≥30 ng/mL)分组差异显著(log rank检验p=0.016)。
- 非椎体骨折发生率在5年、10年和15年随访中按25(OH)D水平分组差异均显著(p<0.001、p=0.001、p=0.017)。
- 5年内与≥30 ng/mL组相比,<10 ng/mL组临床骨折HR 4.93(p=0.009)、非椎体骨折HR 6.55(p=0.005);10–20 ng/mL组临床骨折HR 3.00(p=0.034)、非椎体骨折HR 3.49(p=0.036)。
- 5年内与≥20 ng/mL组相比,<20 ng/mL组临床骨折HR 1.72(p=0.010)、非椎体骨折HR 2.45(p<0.001)、脆性骨折HR 2.00(p=0.032)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We found that community-dwelling women with 25-hydroxyvitamin D levels <20 ng/mL compared to levels ≥20 ng/mL indicated increased risks for clinical, non-vertebral, and fragility fractures during 5 years. Furthermore, the increased risks of non-vertebral fractures remained significant in 10 and 15 years after adjusting for age and bone mineral density. INTRODUCTION: We examined whether total 25-hydroxyvitamin D (25[OH]D) levels are associated with fracture risk over 15 years in a Japanese female cohort. METHODS: Of 1437 community-dwelling women aged ≥50 years in the baseline survey, 1236 provided information regarding fractures during a 15-year follow-up period. The analysis included 1211 women without early menopause or diseases affecting bone metabolism. RESULTS: Over 15 years, 269 clinical (224 non-vertebral, 149 fragility) fracture events were confirmed. Incidence rates categorized by 25(OH)D levels (<10, 10-20, 20-30, and ≥30 ng/mL) indicated a significant divergence for any clinical fractures in 5 years (log rank test p = 0.016) and for non-vertebral fractures in 5, 10, and 15 years (p < 0.001, p = 0.001, p = 0.017, respectively). Hazard ratios (HRs) for 25(OH)D levels <10 and 10-20 ng/mL compared to levels ≥30 ng/mL during 5 years indicated significances for clinical fractures (HR 4.93 with p = 0.009, HR 3.00 with p = 0.034) and for non-vertebral fractures (HR 6.55 with p = 0.005, HR 3.49 with p = 0.036). Those with levels <20 ng/mL compared to those with levels ≥20 ng/mL indicated significant increased risks for clinical fractures (HR 1.72 with p = 0.010), non-vertebral fractures (HR 2.45 with p < 0.001), and fragility fractures (HR 2.00 with p = 0.032) in 5 years. The HR of non-vertebral fractures for levels <20 ng/mL remained significant during 15 years (HR 1.42 with p = 0.012) after adjustment for age and femoral neck bone mineral density. CONCLUSIONS: Low 25(OH)D levels, especially <20 ng/mL, were associated with elevated fracture risks in Japanese women.
引用
- Tamaki J, Iki M, Sato Y, et al. Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int. 2017. PMID: 28243705. doi:10.1007/s00198-017-3967-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。